3D Bioprinters Market: Current Analysis and Forecast (2023-2030)


Emphasis on Technology (Extrusion Bioprinting, Inkjet Bioprinting, Laser-Assisted Bioprinting, and Others); Application (Drug Development, Tissue Engineering & Regenerative Medicine, and Others); and End-Users (Hospitals, Research Institutions, and Pharmaceutical Companies); and Region/Country







Report ID:



  Get a Sample
Report Description
Table of content
Research Methodology
Reviews (0)

Report Description

3D Bioprinters Market
3D Bioprinters Market

The 3D Bioprinters Market is expected to grow at a strong CAGR of ~20% during the forecast period. The global 3D bioprinters market is witnessing rapid expansion, with North America, Europe, and the Asia Pacific leading the charge. The market is segmented based on technology, end-users, and applications, showcasing the diverse range of possibilities offered by 3D bioprinting. Innovations in bioprinting technologies, such as extrusion, inkjet, and laser-assisted bioprinting, have opened avenues for the precise fabrication of complex tissues and organ constructs. The 3D bioprinters market is experiencing remarkable growth and transformation, driven by breakthroughs in tissue engineering, regenerative medicine, and drug development. As the demand for personalized healthcare solutions and organ transplantation alternatives rises, 3D bioprinting technology emerges as a game-changer in the medical field.

Emulate, a biotech company, introduced liver-on-a-chip, a 3D bioprinted miniaturized human liver model on a microfluidic platform. This advancement allows for more accurate and efficient drug testing, reducing the reliance on animal models. 3D Systems and Stratasys are leading the charge in creating personalized implants and prosthetics using biocompatible materials and advanced 3D bioprinting techniques. These custom-made implants enhance patient outcomes and improve overall quality of life.

Some of the major players operating in the market include Organovo Holdings Inc., BICO, Stratasys, CYFUSE BIOMEDICAL K.K., REGEMAT 3D SL, Allevi Inc., Inventia Life Science, Envisiontec US LLC, ROKIT HEALTHCARE INC., and GeSim.

Insights Presented in the Report

“Amongst application, the tissue engineering & regenerative medicine category is expected to dominate the market”

By application, the market is segmented into drug development, tissue engineering & regenerative medicine, and others. Among these, tissue engineering & regenerative medicine captured the majority share of the 3D Bioprinters market in 2022, tissue engineering and regenerative medicine offer a promising solution to the shortage of donor organs for transplantation. Bioprinting enables the creation of patient-specific tissues and organs using the patient’s cells, reducing the risk of rejection and eliminating the need for traditional organ donors.

 “North America dominated the 3D Bioprinters Market in 2022”

North America dominated the 3D Bioprinters market in 2022. North America was expected to continue growing in the 3D bioprinters market due to several factors that create a conducive environment for the adoption and advancement of this technology. Researchers and companies in North America made advancements in bioprinting complex organs for transplantation. The development of functional heart tissue and liver constructs demonstrated the potential for personalized organ transplants. Biotech companies and research institutions in the region explored the use of 3D bioprinted tissues for preclinical drug testing, aiming to improve drug development processes and reduce reliance on animal testing.

3D Bioprinters Market Report Coverage

3D Bioprinters Market
3D Bioprinters Market

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.


Customization Options:

The global 3D Bioprinters market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Main Objective


2.1.Research Process of the 3D Bioprinters Market
2.2.Research Methodology of the 3D Bioprinters Market
2.3.Respondent Profile   








6.1.Extrusion Bioprinting  
6.2.Inkjet Bioprinting  
6.3.Laser-Assisted Bioprinting


7.1.Drug Development    
7.2.Tissue Engineering & Regenerative Medicine 


8.2.Research Institutions 
8.3.Pharmaceutical Companies


9.1. North America   
 9.1.3.Rest of North America
 9.2.6.Rest of Europe 
 9.3.4.Rest of APAC 
9.4.Rest of the World   


10.1.Market Drivers
10.2.Market Challenges
10.3.Impact Analysis








14.1.Competitive Landscape 
 14.1.1.Porters Fiver Forces Analysis


15.1.Organovo Holdings Inc. 
15.6.Allevi Inc.   
15.7.Inventia Life Science 
15.8.Envisiontec US LLC 




Research Methodology

Research Methodology for the 3D Bioprinters Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global 3D Bioprinters market were the three major steps undertaken to create and analyze the adoption of 3D Bioprinters in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global 3D Bioprinters market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the 3D Bioprinters market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the 3D Bioprinters market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as technology, application, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the 3D Bioprinters market. Further, we conducted factor analysis using dependent and independent variables such as technology, application, and end-users of the 3D Bioprinters market. A thorough analysis was conducted of demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the 3D Bioprinters market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global 3D Bioprinters market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of the 3D Bioprinters market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global 3D Bioprinters market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market


Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions 

3D Bioprinters Market
3D Bioprinters Market

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global 3D Bioprinters market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the technology, application, and end-users in the global 3D Bioprinters market.

The main objective of the Global 3D Bioprinters Market Study

The current & future market trends of the global 3D Bioprinters market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the 3D Bioprinters market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of the technology, application, and end-users
  • Define and analysis of the regulatory framework for the 3D Bioprinters industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the 3D Bioprinters market for the major region
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
  • Company profiles of the 3D Bioprinters market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry


You can also purchase parts of this report. Do you want to check out a section wise
price list?


There are no reviews yet.

Be the first to review “3D Bioprinters Market: Current Analysis and Forecast (2023-2030)”

Your email address will not be published.